Corteva Plunges 24% as Brazil Channel Glut Cuts Guidance
Corteva fell 24% on November 12 after cutting 2026 EBITDA guidance by roughly $175M to $1.1B-$1.125B from approximately $1.3B. The company blamed Brazil's crop-protection channel, where excess distrib
Corteva Craters 24% as Brazil Collapses 2026 Outlook
NEW YORK, November 13 —
Corteva, Inc. (CTVA) fell 24% on November 12 after cutting its full-year 2026 EBITDA outlook by roughly $175 million from guidance issued at a September investor day. By the CEO's own account, Brazil's crop-protection channel was already deteriorating that same month. The distance between those two facts is what investors are pricing.
- Q3 net sales fell 9% to $1.6B; operating EBITDA declined 17% to $222M; Q3 net loss widened to $568M.
- Full-year EBITDA guidance cut to $1.1B, $1.125B from ~$1.3B; Latin America sales fell 31%.
- CTVA closed at $9.19 on November 12, down 24.3%; trailing one-month decline: 31.4%.
The September Problem
Corteva, which sells herbicides, insecticides, nitrogen stabilizers, and seed-applied technologies across four continents, held its investor day in September 2026 and published an EBITDA target of approximately $1.3 billion for the full year. Q3 ended September 30. CEO Luke Kissam now says Brazil's market conditions "deteriorated sharply in the final weeks of the third quarter" and that conditions have "continued to see negative development since then." Management did not adjust guidance at the investor day; they issued it. The November 12 8-K filing answers the question of visibility implicitly, and harshly.
The Channel Hole
The Brazil failure has a specific anatomy. CEO Kissam described it plainly: "Too much of the product we sold into the Brazil channel last year didn't go to ground." Inventory sold to distributors never reached end-use farmers, leaving excess stock lodged in the channel. CFO Jeff Rudolph attributed the entire guidance reduction to Brazil: lower prices, lower volumes, excess distributor inventory. That dynamic drove Latin America sales down 31% in Q3, wiping out gains in North America, EMEA, and Asia Pacific. Corteva has since frozen hiring and begun a cost review, but those levers address cash burn rather than the pace of inventory clearance.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| CTVA | $6.1B | 8.2x | +22.2% |
| DD | $20.5B | 18.9x | +27.8% |
| DOW | $24.0B | 18.1x | +40.8% |
| IFF | $20.1B | 20.8x | +22.6% |
| NTR | $33.8B | 14.0x | +21.7% |
| CF | $18.3B | 10.7x | +46.1% |
Why the 2027 Thesis Is Borrowed Credibility
Management guides four to eight quarters for an operational transformation, projecting a 2027 return to growth. That forecast comes from the same team that published the $1.3 billion EBITDA target in September and saw it reversed within weeks. Following the Vylor spinoff, Corteva carries $4.77 billion in debt against a $6.13 billion market cap, leaving thin cushion if Brazil's channel takes longer to clear. The prior quarter's 41.8% EPS miss against consensus shows this problem predates Q3. A confirmed Brazil inventory drawdown is the number that changes the thesis; absent that signal, the DCF calculator applied to CTVA's debt profile tells a harder story. Run the free Corteva, Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
Why did Corteva stock fall 24% on November 12?
Corteva slashed its full-year 2026 EBITDA guidance by roughly $175M to $1.1B-$1.125B from approximately $1.3B. The company attributed the cut to excess distributor inventory in Brazil's crop-protection channel that never reached end-use farmers, combined with deteriorating market conditions.
What exactly is the Brazil channel problem?
CEO Luke Kissam said "Too much of the product we sold into the Brazil channel last year didn't go to ground," leaving excess stock lodged with distributors instead of reaching farmers. This inventory glut has not cleared, forcing the company to lower prices and volumes while the channel clears.
How severe was Q3 2026 for Corteva?
Q3 net sales fell 9% to $1.6B, operating EBITDA declined 17% to $222M, and net loss widened to $568M. Latin America sales fell 31%, wiping out gains across North America, EMEA, and Asia Pacific.
Can Corteva really recover in 2027?
Management guides for a return to growth in 2027, but the forecast comes from the same team that published a $1.3B EBITDA target in September and saw it reversed within weeks. Corteva carries $4.77B in debt against a $6.13B market cap, leaving limited cushion if Brazil's channel inventory takes longer to clear.
Corteva fell 24.3% on November 12 after slashing its full-year 2026 EBITDA guidance by roughly $175–200 million, citing a sudden collapse in Brazil's crop-protection distribution channel. The same management team that projected $1.3 billion in EBITDA at a September investor day now says Brazil will show no meaningful near-term recovery — yet is still forecasting a return to growth in 2027.